These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18123723)

  • 21. Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL: the "PSA negative" patients.
    Birtle AJ; Freeman A; Masters JR; Payne HA; Harland SJ;
    Cancer; 2003 Dec; 98(11):2362-7. PubMed ID: 14635070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic small cell carcinoma of the prostate: Population-based analysis of patient characteristics and treatment paradigms.
    Cohen A; Richards KA; Patel S; Weiner A; Eggener SE; Szmulewitz RZ
    Urol Oncol; 2015 Feb; 33(2):70.e1-7. PubMed ID: 25044254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prostate carcinoma; Metastasis in the Schengen area].
    NOVOTNY O
    Monatsschr Ohrenheilkd Laryngorhinol; 1949 Jan; 83(1):30-3. PubMed ID: 18116638
    [No Abstract]   [Full Text] [Related]  

  • 24. [On a case of metastasis to the corpora cavernosa of the penis of carcinoma of the prostate].
    GAROFALO F
    Arch Ital Urol; 1963 Jun; 36():138-48. PubMed ID: 13946620
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prostatic xantho-carcinoma; skin and mucous metastases].
    GOLAY M
    Rev Med Suisse Romande; 1949 Feb; 69(2):107-20. PubMed ID: 18111092
    [No Abstract]   [Full Text] [Related]  

  • 26. COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67.
    Richardsen E; Uglehus RD; Due J; Busch C; Busund LT
    Cancer Epidemiol; 2010 Jun; 34(3):316-22. PubMed ID: 20409773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrahepatic portal hypertension secondary to metastatic carcinoma of the prostate.
    Attila T; Datta MW; Sudakoff G; Abu-Hajir M; Massey BT
    WMJ; 2007 Feb; 106(1):34-6. PubMed ID: 17393756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous metastasis of prostate cancer: a case report and review of the literature with bioinformatics analysis of multiple healthcare delivery networks.
    Brown GT; Patel V; Lee CC
    J Cutan Pathol; 2014 Jun; 41(6):524-8. PubMed ID: 24456209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical metastases from prostate cancer: 10-year experience at a single institution.
    Vinjamoori AH; Jagannathan JP; Shinagare AB; Taplin ME; Oh WK; Van den Abbeele AD; Ramaiya NH
    AJR Am J Roentgenol; 2012 Aug; 199(2):367-72. PubMed ID: 22826398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastasizing adamantinoma-like growth invading the skull and early carcinoma of the prostate.
    Le SOUEF JD
    Med J Aust; 1946 Dec; 2(24):841. PubMed ID: 20281040
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostate carcinoma--the value of T stage and grade in predicting metastases and prognosis. A cost-effective approach to clinical staging.
    Allen FJ; de Kock ML; de Klerk DP; Heyns CF
    S Afr J Surg; 1991 Mar; 29(1):15-8. PubMed ID: 1905062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mastoid recurrence after radiotherapy for nasopharyngeal carcinoma: two case studies.
    Zhang X; Luo J; Gao L; Xu G
    Head Neck; 2011 Oct; 33(10):1535-8. PubMed ID: 20848413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The metastasis of prostatic cancer and the methods for its demonstration].
    Tsvetkov M; Neĭkov K; Mladenov M; Topov Iu; Kumanov Kh
    Khirurgiia (Sofiia); 1997; 50(1):20-7. PubMed ID: 9379613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Features of unusual metastases from prostate cancer.
    Long MA; Husband JE
    Br J Radiol; 1999 Oct; 72(862):933-41. PubMed ID: 10673942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival.
    Cheville JC; Tindall D; Boelter C; Jenkins R; Lohse CM; Pankratz VS; Sebo TJ; Davis B; Blute ML
    Cancer; 2002 Sep; 95(5):1028-36. PubMed ID: 12209687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metastases of prostatic cancer].
    Samsonov VA
    Arkh Patol; 1985; 47(8):58-61. PubMed ID: 4074149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen.
    Ghazizadeh M; Kagawa S; Maebayashi K; Izumi K; Kurokawa K
    Urol Int; 1984; 39(1):9-12. PubMed ID: 6203202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The truth is in the water: metastatic prostate cancer presenting as an intermittent facial nerve palsy.
    Wooles N; Gupta S; Wilkin-Crowe H; Juratli A
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25911361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence of unsuspected metastases from clinically benign prostate glands with latent prostate carcinoma.
    Brawn PN; Kuhl D; Speights VO; Johnson CF; Lind M
    Arch Pathol Lab Med; 1995 Aug; 119(8):731-3. PubMed ID: 7646331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.